Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ormsalva is a topical liniment brand used for the relief of muscle and joint pain, soreness, and stiffness. Developed and marketed by Evolan Pharma, the product line includes variants such as Ormsalva Aktiv, Ormsalva Original, and Ormsalva Kylande. The formulations typically utilize a combination of active ingredients including *Arnica montana* extract, menthol, and camphor. These components work through counter-irritant and anti-inflammatory mechanisms to provide warming or cooling sensations, improve local blood circulation, and reduce pain associated with physical exertion or minor musculoskeletal injuries. It is a well-established OTC brand in the Nordic market, particularly within the sports and physical therapy sectors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ormsalva.